Follow Recommended Dosages: Stick to the recommended dosage guidelines provided by the manufacturer or consult with a healthcare professional for personalized advice
B.MuthiaS.LindaR.et al (2024)
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide) carry the clinical evidence: STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
Back to life : You walk out and keep doing your thing
Do not use it without a qualified prescriber if you have a personal or family history of medullary thyroid carcinoma or MEN 2
It is highly possible that activity of other GPCRs, and medications that affect their signaling, modulate GLP-1 M activity in cells